The Clorox Company (NYSE:CLX) Shares Sold by Truist Financial Corp

Truist Financial Corp decreased its holdings in shares of The Clorox Company (NYSE:CLX) by 13.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 43,470 shares of the company’s stock after selling 6,639 shares during the period. Truist Financial Corp’s holdings in Clorox were worth $6,198,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Fortitude Family Office LLC acquired a new position in Clorox during the 4th quarter worth approximately $29,000. Tyler Stone Wealth Management increased its position in Clorox by 64.5% during the 3rd quarter. Tyler Stone Wealth Management now owns 255 shares of the company’s stock worth $33,000 after purchasing an additional 100 shares during the period. Hartford Financial Management Inc. increased its position in Clorox by 57.1% during the 4th quarter. Hartford Financial Management Inc. now owns 256 shares of the company’s stock worth $37,000 after purchasing an additional 93 shares during the period. Valley National Advisers Inc. grew its holdings in shares of Clorox by 458.3% in the 4th quarter. Valley National Advisers Inc. now owns 268 shares of the company’s stock worth $38,000 after acquiring an additional 220 shares during the period. Finally, BKM Wealth Management LLC purchased a new position in Clorox in the 4th quarter valued at approximately $41,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Price Performance

CLX stock opened at $138.23 on Friday. The Clorox Company has a 52-week low of $114.68 and a 52-week high of $176.24. The stock’s fifty day simple moving average is $148.45 and its 200-day simple moving average is $143.17. The company has a quick ratio of 0.57, a current ratio of 0.90 and a debt-to-equity ratio of 9.73. The stock has a market capitalization of $17.17 billion, a price-to-earnings ratio of 71.62, a price-to-earnings-growth ratio of 2.18 and a beta of 0.44.

Clorox (NYSE:CLX) last issued its earnings results on Tuesday, April 30th. The company reported $1.71 earnings per share for the quarter, beating analysts’ consensus estimates of $1.33 by $0.38. Clorox had a return on equity of 302.49% and a net margin of 3.33%. The firm had revenue of $1.81 billion for the quarter, compared to analysts’ expectations of $1.87 billion. During the same quarter last year, the firm earned $1.51 earnings per share. The firm’s revenue for the quarter was down 5.3% compared to the same quarter last year. Equities research analysts expect that The Clorox Company will post 5.8 EPS for the current year.

Clorox Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Investors of record on Wednesday, April 24th will be issued a $1.20 dividend. This represents a $4.80 dividend on an annualized basis and a yield of 3.47%. The ex-dividend date is Tuesday, April 23rd. Clorox’s payout ratio is currently 248.71%.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on CLX. DA Davidson reaffirmed a “neutral” rating and issued a $162.00 price objective on shares of Clorox in a research note on Wednesday, April 17th. Barclays dropped their price objective on Clorox from $136.00 to $132.00 and set an “underweight” rating for the company in a research note on Thursday. Morgan Stanley reaffirmed an “equal weight” rating and issued a $160.00 price objective on shares of Clorox in a research note on Tuesday, March 26th. The Goldman Sachs Group began coverage on Clorox in a research note on Friday, March 1st. They issued a “sell” rating and a $140.00 price objective for the company. Finally, Deutsche Bank Aktiengesellschaft dropped their price objective on Clorox from $155.00 to $151.00 and set a “hold” rating for the company in a research note on Wednesday, April 17th. Four analysts have rated the stock with a sell rating and thirteen have assigned a hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $146.43.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.